Mercieri M, Palmisani S, De Blasi R A, et al. Low-dose buprenorphine infusion to prevent postoperative hyperalgesia in patients undergoing major lung surgery and remifentanil infusion: a double-blind, randomized, active-controlled trial [J] .Br J Anaesth,2017,119(4):792-802.
Campillo A, Gonzalez-Cuello A, Cabanero D, et al. Increased spinal dynorphin levels and phosphor-extrancellular signal-regulated kinases 1 and 2 c-Fos immunoreactivity after surgery under remifentanil anesthesia in mice [J].Mol Pharmacol,2010,77(2):185-194.
[4]
Corder G, Tawfik V L, Wang D, et al. Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia[J]. Nat Med,2017, 23:164-173.
[5]
Virk M S, Williams J T. Agonist-specific regulation of μ-opioid receptor desensitization and recovery from desensitization[J]. MolPharmacol, 2008,73(4):1301-1308.
[6]
Marc D K, Patricia L H, Hilde W. The short-lasting analgesia and long-term antihyperalgesic effect of intrathecal clonidine in patients undergoing colonic surgery [J]. Anesth Analg,2005,101(2):566-572.
[7]
Roeckel L A, Le C GM, Gavériaux-Ruff C, et al. Opioid-induced hyperalgesia: Cellular and molecular mechanisms[J]. Neuroscience,2016, Dec 3,338:160-182.
[8]
Lee M,Silverman S M,Hansen H,et al. A comprehensive review of opioid-induced hyperalgesia [J]. Pain Physician, 2011,14(2):145-161.
[9]
Dogrul A, Bilsky E J, Ossipov M H, et al. Spinal L-type calcium channel blockade abolishes opioid-induced sensory hypersensitivity and antinociceptive tolerance [J]. AnesthAnalg,2005,101(6):1730-1735.
[10]
Yuan Yuan, Wang Jingyao, Yuan Fang, et al. Glycogen synthase kinase-3βcontributes to remifentanil-induced postoperative hyperalgesia via regulating N-Methyl-d-Aspartate receptor trafficking[J].Anesth Analg,2013,116(2):473-481.
[11]
Chu L F, D’Arcy N, Brady C, et al. Analgesic tolerance without demonstrable opioid-induced hyperalgesia:a double-blinded, randomized, placebo-controlled trialof sustained-release morphine for treatment of chronicnonradicular low-back pain [J].Pain,2012,153:1583-1592.
[12]
Comelon M, Raeder J, Stubhaug A, et al. Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia [J].Br J Anaesth,2016,116:524-530.
[13]
Zhao M, Joo D T. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance [J]. Anesthesiology,2008,109(2):308-317.
[14]
Lena W, David C Y, Alexander T. Opioid-induced hyperalgesia in clinical anesthesia practice: what has remained from theoretical concepts and experimental studies?[J].Curr Opin Anesthesiol, 2017, 30:458-465.
[15]
Chu L F, Dairmont J, Zamora A K et al.The endogenous opioid system is not involved in modulation of opioid-induced hyperalgesia[J]. J Pain,2011,12(1):108-115.
[16]
Nama S, Meenan D R, Fritz W T.The use of sub-anesthetic intravenous ketamine and adjuvant dexmedetomidine when treating acute pain from CRPS[J].Pain Physician,2010,13(4):365-368.
[17]
Amr Y M.Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: aprospective,randomized,double blind trial [J]. Pain Physician,2010,13(3):245-249.
Yuguang H,Xia J,Hailan W,et al. Ketamine and lornoxicam for preventing a fentanyl-induced increase in postoperative morphine requirement.[J]. Anesth Analg,2008,107(6):2032-2037.
[21]
Q B Li, L Chang, F Ye, et al. Role of spinal cyclooxygenase-2 and prostaglandin E2 in fentanyl-induced hyperalgesia in rats[J]. Br J Anaesth, 2018,120 (4): 827-835
Kroin J S,Takatori M,Li J,et al. Upregulation of dorsal horn microglial cyclooxygenase-1 and neuronal cyclooxygenase-2 after thoracic deep muscle incisions in the rat [J]. Anesth Analg, 2008,106(4):1288-1295.
[24]
Cristina S, Alberto N, Claudia C, et al. Remifentanil-induced postoperative hyperalgesia: current perspectives on mechanisms and therapeutic strategies[J]. Local and Reg Anesth, 2018,11:15-23.
[25]
Marion L, Sanford S, Hans H. A comprehensive review of opioid-induced hyperalgesia[J]. Pain Physician,2011,14(2):145-161.
[26]
Selpeter S R, Buckley J S, Bruera E. The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia[J].J Palliat Med,2013,16(6):616-622.
[27]
Wang H, Wang Z, Mi W, et al. Propofol effectively inhibits lithium-pilocarpine-induced status pilepticus in rats via downregulation of N-methyl-D-aspartate receptor 2B subunit expression[J].Neural Regen Res,2012, 7(11):827-832.
2018, Vol. 29 
